Bando et al. perform a phase II trial of atezolizumab monotherapy following platinum-based definitive chemoradiotherapy in patients with unresectable locally advanced esophageal squamous cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback